Synopsis:

Senores Pharmaceuticals jumped sharply after its net profit grew 131% YoY to Rs 30.1 crore due to robust growth in its regulated markets and increased efficiency. Due to strong worldwide demand for its complex generics, revenue increased 56% to Rs 153 crore, and margins improved significantly.

The shares of this leading manufacturer and developer of affordable and high-quality complex generics are in focus after reporting stellar Q2 results. In this article, we will dive more into the details of it.

With a market capitalisation of Rs 3,685 crore, the shares of Senores Pharmaceuticals Ltd made a day high of Rs 829.55 per share, up by 8 percent from its previous day closing price of Rs 766.80 per share. Post its listing on the stock exchanges in December 2024, the stock has

See Full Page